Anaconda Biomed Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 46

Employees

  • Latest Deal Type
  • Series E

  • Latest Deal Amount
  • $56.8M

  • Investors
  • 11

Anaconda Biomed General Information

Description

Developer of neurovascular medical devices designed to treat ischemic stroke. The company develops funnel catheters, stent retrievers, neurovascular sheaths, and guidewires, utilizing proprietary funnel catheter technology to improve clot capture and maximize brain reperfusion, enabling neurointerventional surgeons to treat stroke patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Carrer d'Eivissa, 56
  • Sant Quirze del Vallès
  • 08192 Barcelona
  • Spain
+34 933
Primary Industry
Therapeutic Devices
Vertical(s)
Corporate Office
  • Carrer d'Eivissa, 56
  • Sant Quirze del Vallès
  • 08192 Barcelona
  • Spain
+34 933

Anaconda Biomed Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anaconda Biomed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series E) 23-Sep-2026 $56.8M Completed Generating Revenue
6. Later Stage VC 09-Jan-2025 Completed Generating Revenue
5. Debt - General 29-Jul-2021 Completed Pre-Clinical Trials
4. Early Stage VC (Series B) 04-Dec-2019 Completed Pre-Clinical Trials
3. Early Stage VC (Series A) 23-May-2017 Completed Pre-Clinical Trials
2. Early Stage VC Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view Anaconda Biomed’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Anaconda Biomed Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of neurovascular medical devices designed to treat ischemic stroke. The company develops funnel catheters, ste
Therapeutic Devices
Barcelona, Spain
46 As of 2026

Plano, TX
 

Marlton, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Anaconda Biomed Competitors (8)

One of Anaconda Biomed’s 8 competitors is Vesalio, a Venture Capital-Backed company based in Plano, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vesalio Venture Capital-Backed Plano, TX
Impulse Dynamics Venture Capital-Backed Marlton, NJ
Eodyne Systems Accelerator/Incubator Backed Barcelona, Spain
TISSIUM Venture Capital-Backed Paris, France
Artivion Formerly PE-Backed Kennesaw, GA
You’re viewing 5 of 8 competitors. Get the full list »

Anaconda Biomed Patents

Anaconda Biomed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025248755-A1 Thrombectomy system and method of use Pending 17-Oct-2024
WO-2026017647-A1 A thrombectomy apparatus for extracting a thrombus from a blood vessel Pending 15-Jul-2024
EP-4452098-B1 An intravascular device with an improved attachment of its elements Active 21-Dec-2021
EP-4806390-A2 An intravascular device with an improved attachment of its elements Pending 21-Dec-2021
EP-4806390-A3 An intravascular device with an improved attachment of its elements Pending 21-Dec-2021 A61B17/221
To view Anaconda Biomed’s complete patent history, request access »

Anaconda Biomed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anaconda Biomed Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
CDTi Advanced Materials Corporation Minority
COFIDES Impact Investing Minority
INNVIERTE SICC Government Minority
Asabys Partners Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 11 investors. Get the full list »

Anaconda Biomed FAQs

  • When was Anaconda Biomed founded?

    Anaconda Biomed was founded in 2015.

  • Where is Anaconda Biomed headquartered?

    Anaconda Biomed is headquartered in Barcelona, Spain.

  • What is the size of Anaconda Biomed?

    Anaconda Biomed has 46 total employees.

  • What industry is Anaconda Biomed in?

    Anaconda Biomed’s primary industry is Therapeutic Devices.

  • Is Anaconda Biomed a private or public company?

    Anaconda Biomed is a Private company.

  • What is Anaconda Biomed’s current revenue?

    The current revenue for Anaconda Biomed is .

  • How much funding has Anaconda Biomed raised over time?

    Anaconda Biomed has raised $107M.

  • Who are Anaconda Biomed’s investors?

    CDTi Advanced Materials, COFIDES, INNVIERTE SICC, Asabys Partners, and are 5 of 11 investors who have invested in Anaconda Biomed.

  • Who are Anaconda Biomed’s competitors?

    Vesalio, Impulse Dynamics, Eodyne Systems, TISSIUM, and Artivion are some of the 8 competitors of Anaconda Biomed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process